Colistimethate, a potent antimicrobial compound, holds immense value within the biomedical industry for the treatment of severe infections. Specifically developed to combat multidrug-resistant Gram-negative bacteria, especially the formidable Pseudomonas aeruginosa, it operates within the realm of polymyxin antibiotics. By intricately disrupting the bacterial cell membrane, Colistimethate displays its efficacy. With the flexibility of three administration routes - inhalation, injection, or nebulization - this product epitomizes versatility, offering a myriad of therapeutic choices to tackle a diverse range of drug-resistant infections effectively.
CAT No: R1998
CAS No:12705-41-8
Chemical Name:pentasodium;[2-[17-(1-hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-(6-methyloctanoylamino)-4-(sulfonatomethylamino)butanoyl]amino]butanoyl]amino]-4-(sulfonatomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15,18,23-heptaoxo-11,14-bis[2-(sulfonatomethylamino)ethyl]-1,4,7,10,13,16,19-heptazacyclotricos-2-yl]ethylamino]methanesulfonate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.